Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

Español • Italiano • Sardu • English | PDF+


  Leukemia

  Free Subscription


26.08.2019

1 Acta Haematol
1 Am J Clin Pathol
4 Blood
1 BMC Cancer
1 BMC Genomics
6 Bone Marrow Transplant
1 Cancer
1 Clin Infect Dis
3 Int J Hematol
1 J Biol Chem
1 J Clin Oncol
1 J Virol
3 Leuk Res
6 Leukemia
2 N Engl J Med
2 Oncogene
1 Oncol Rep
3 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Haematol

  1. JIANG H, Li C, Liu Z
    Expression and Relationship of SAMHD1 with Other Apoptotic and Autophagic Genes in Acute Myeloid Leukemia Patients.
    Acta Haematol. 2019 Aug 21:1-9. doi: 10.1159/000500822.
    PubMed     Text format     Abstract available


    Am J Clin Pathol

  2. VAN DER NEST BM, Leslie C, Joske D, Radeski D, et al
    Peripheral T-Cell Lymphoma Arising in Patients With Chronic Lymphocytic Leukemia.
    Am J Clin Pathol. 2019 Aug 21. pii: 5552737. doi: 10.1093.
    PubMed     Text format     Abstract available


    Blood

  3. TANASI I, Ba I, Sirvent N, Braun T, et al
    Efficacy of Tyrosine Kinase Inhibitors in Ph-like Acute Lymphoblastic Leukemia harboring ABL-class Rearrangements.
    Blood. 2019 Aug 21. pii: blood.2019001244. doi: 10.1182/blood.2019001244.
    PubMed     Text format    

  4. SARRAF YAZDY M, Mato AR, Cheson BD
    Combinations or sequences of targeted agents in CLL: is the whole greater than the sum of its parts (Aristotle, 360 BC)?
    Blood. 2019;133:121-129.
    PubMed     Text format     Abstract available


  5. Steele AJ, Prentice AG, Hoffbrand AV, et al. 2-phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. Blood. 2009;114(6):1217-1225.
    Blood. 2019;134:719-721.
    PubMed     Text format    


  6. Oral arsenic for acute promyelocytic leukemia.
    Blood. 2019;134:659.
    PubMed     Text format    


    BMC Cancer

  7. LI X, Dong Y, Li Y, Ren R, et al
    Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm study.
    BMC Cancer. 2019;19:819.
    PubMed     Text format     Abstract available


    BMC Genomics

  8. HAJIRAMEZANALI E, Imani M, Braga-Neto U, Qian X, et al
    Scalable optimal Bayesian classification of single-cell trajectories under regulatory model uncertainty.
    BMC Genomics. 2019;20.
    PubMed     Text format     Abstract available


    Bone Marrow Transplant

  9. NAGLER A, Ruggeri A
    Haploidentical stem cell transplantation (HaploSCT) for patients with acute leukemia-an update on behalf of the ALWP of the EBMT.
    Bone Marrow Transplant. 2019;54.
    PubMed     Text format     Abstract available

  10. JACOBY E
    The role of allogeneic HSCT after CAR T cells for acute lymphoblastic leukemia.
    Bone Marrow Transplant. 2019;54.
    PubMed     Text format     Abstract available

  11. PIERINI A, Ruggeri L, Mancusi A, Carotti A, et al
    T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease.
    Bone Marrow Transplant. 2019;54.
    PubMed     Text format     Abstract available

  12. EINSELE H, Rasche L, Topp MS, Martin Kortum K, et al
    The use of bispecific antibodies to optimize the outcome of patients with acute leukemia, lymphoma and multiple myeloma after SCT.
    Bone Marrow Transplant. 2019;54.
    PubMed     Text format     Abstract available

  13. SCHLEGEL P, Jung G, Lang AM, Doring M, et al
    ADCC can improve graft vs leukemia effect after T- and B-cell depleted haploidentical stem cell transplantation in pediatric B-lineage ALL.
    Bone Marrow Transplant. 2019;54.
    PubMed     Text format     Abstract available

  14. PIERINI A, Ruggeri L, Carotti A, Falzetti F, et al
    The "ultimate" haploidentical transplantation for the elderly with high-risk acute myeloid leukemia.
    Bone Marrow Transplant. 2019;54.
    PubMed     Text format    


    Cancer

  15. JABBOUR EJ, Gokbuget N, Kantarjian HM, Thomas X, et al
    Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 study.
    Cancer. 2019 Aug 21. doi: 10.1002/cncr.32335.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  16. GALLOWAY-PENA JR, Shi Y, Peterson CB, Sahasrabhojane P, et al
    Gut Microbiome Signatures are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia.
    Clin Infect Dis. 2019 Aug 22. pii: 5553100. doi: 10.1093.
    PubMed     Text format     Abstract available


    Int J Hematol

  17. ZHOU F, Zhou F, Du M, Liu L, et al
    Comprehensive prognostic scoring systems could improve the prognosis of adult acute myeloid leukemia patients.
    Int J Hematol. 2019 Aug 22. pii: 10.1007/s12185-019-02721.
    PubMed     Text format     Abstract available

  18. SAKAGUCHI M, Yamaguchi H, Kuboyama M, Najima Y, et al
    Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemia.
    Int J Hematol. 2019 Aug 20. pii: 10.1007/s12185-019-02720.
    PubMed     Text format     Abstract available

  19. MORIYAMA K, Hori T
    BCR-ABL induces tyrosine phosphorylation of YAP leading to expression of Survivin and Cyclin D1 in chronic myeloid leukemia cells.
    Int J Hematol. 2019 Aug 19. pii: 10.1007/s12185-019-02726.
    PubMed     Text format     Abstract available


    J Biol Chem

  20. DEMBITZ V, Tomic B, Kodvanj I, Simon JA, et al
    The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 kinase via pyrimidine depletion.
    J Biol Chem. 2019 Aug 20. pii: RA119.009396. doi: 10.1074/jbc.RA119.009396.
    PubMed     Text format     Abstract available


    J Clin Oncol

  21. ANGENENDT L, Rollig C, Montesinos P, Martinez-Cuadron D, et al
    Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts.
    J Clin Oncol. 2019 Aug 20:JCO1900416. doi: 10.1200/JCO.19.00416.
    PubMed     Text format     Abstract available


    J Virol

  22. PI R, Iwasaki A, Sewald X, Mothes W, et al
    Murine Leukemia Virus exploits innate sensing by TLR7 in B-1 cells to establish infection and local spread in mice.
    J Virol. 2019 Aug 21. pii: JVI.00930-19. doi: 10.1128/JVI.00930.
    PubMed     Text format     Abstract available


    Leuk Res

  23. SAYAR H, Cripe LD, Saliba AN, Abu Zaid M, et al
    Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials.
    Leuk Res. 2019;77:30-33.
    PubMed     Text format    

  24. LUO H, Zhang S, Li K, Chen XH, et al
    A novel entity of acute myeloid leukaemia with recurrent RARG-rearrangement resembling acute promyelocytic leukaemia.
    Leuk Res. 2019;77:14-16.
    PubMed     Text format    

  25. DRUSBOSKY LM, Vidva R, Gera S, Lakshminarayana AV, et al
    Predicting response to BET inhibitors using computational modeling: A BEAT AML project study.
    Leuk Res. 2019;77:42-50.
    PubMed     Text format     Abstract available


    Leukemia

  26. OFRAN Y, Ringelstein-Harlev S, Slouzkey I, Zuckerman T, et al
    Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemia.
    Leukemia. 2019 Aug 21. pii: 10.1038/s41375-019-0548.
    PubMed     Text format    

  27. KREUZER KA, Furman RR, Stilgenbauer S, Dubowy RL, et al
    The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab.
    Leukemia. 2019 Aug 19. pii: 10.1038/s41375-019-0533.
    PubMed     Text format    

  28. SHEM-TOV N, Peczynski C, Labopin M, Itala-Remes M, et al
    Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT.
    Leukemia. 2019 Aug 19. pii: 10.1038/s41375-019-0544.
    PubMed     Text format     Abstract available

  29. KIM JC, Zuzarte PC, Murphy T, Chan-Seng-Yue M, et al
    Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing.
    Leukemia. 2019 Aug 21. pii: 10.1038/s41375-019-0546.
    PubMed     Text format    

  30. HIXON JA, Andrews C, Kashi L, Kohnhorst CL, et al
    New anti-IL-7Ralpha monoclonal antibodies show efficacy against T cell acute lymphoblastic leukemia in pre-clinical models.
    Leukemia. 2019 Aug 22. pii: 10.1038/s41375-019-0531.
    PubMed     Text format     Abstract available

  31. AWADA H, Rahman S, Durrani J, Asad MF, et al
    Leukemia evolving from paroxysmal nocturnal hemoglobinuria.
    Leukemia. 2019 Aug 20. pii: 10.1038/s41375-019-0555.
    PubMed     Text format    


    N Engl J Med

  32. KATER AP, Levin MD, Niemann CU
    Ibrutinib and Venetoclax for First-Line Treatment of CLL.
    N Engl J Med. 2019;381:788-789.
    PubMed     Text format    

  33. JAIN N, Gandhi V, Wierda W
    Ibrutinib and Venetoclax for First-Line Treatment of CLL. Reply.
    N Engl J Med. 2019;381:789.
    PubMed     Text format    


    Oncogene

  34. BUFFIERE A, Uzan B, Aucagne R, Hermetet F, et al
    T-cell acute lymphoblastic leukemia displays autocrine production of Interleukin-7.
    Oncogene. 2019 Aug 15. pii: 10.1038/s41388-019-0921.
    PubMed     Text format     Abstract available

  35. SECKER KA, Keppeler H, Duerr-Stoerzer S, Schmid H, et al
    Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9.
    Oncogene. 2019 Aug 15. pii: 10.1038/s41388-019-0937.
    PubMed     Text format     Abstract available


    Oncol Rep

  36. ZHANG R, Deng Q, Jiang YY, Zhu HB, et al
    Effect and changes in PD1 expression of CD19 CART cells from T cells highly expressing PD1 combined with reduceddose PD1 inhibitor.
    Oncol Rep. 2019;41:3455-3463.
    PubMed     Text format     Abstract available


    PLoS One

  37. CALDERON-RODRIGUEZ SI, Sanabria-Salas MC, Umana-Perez A
    A comparative proteomic study of plasma in Colombian childhood acute lymphoblastic leukemia.
    PLoS One. 2019;14:e0221509.
    PubMed     Text format     Abstract available

  38. SILVA-JUNIOR AL, Alves FS, Kerr MWA, Xabregas LA, et al
    Acute lymphoid and myeloid leukemia in a Brazilian Amazon population: Epidemiology and predictors of comorbidity and deaths.
    PLoS One. 2019;14:e0221518.
    PubMed     Text format     Abstract available

  39. UTUAMA O, Mukhtar F, Pham YT, Dabo B, et al
    Racial/ethnic, age and sex disparities in leukemia survival among adults in the United States during 1973-2014 period.
    PLoS One. 2019;14:e0220864.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: